Guardant Health (GH) Net Margin (2017 - 2026)

Guardant Health has disclosed Net Margin across 10 years of filings, most recently posting 37.15% for Q1 2026.

• Net Margin for Q1 2026 came in at 37.15%, up 962.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 40.1% (up 1372.0% YoY), and the FY2025 annual result was 42.39%, up 1666.0% from the prior year.
• Net Margin came in at 37.15% for Q1 2026 at Guardant Health, up from 45.68% in the prior quarter.
• In the past five years, Net Margin ranged from a high of 34.96% in Q3 2025 to a low of 210.21% in Q2 2022.
• The 5-year median for Net Margin is 57.91% (2024), against an average of 80.55%.
• Across the five-year window, Net Margin plunged 10427 bps in 2022 and surged 15715 bps in 2023, its largest moves.
• Guardant Health's Net Margin stood at 110.28% in 2022, then fell by 9 bps to 120.63% in 2023, then jumped by 54 bps to 55.0% in 2024, then gained by 17 bps to 45.68% in 2025, then gained by 19 bps to 37.15% in 2026.
• The last three Net Margin figures came in at 37.15% (Q1 2026), 45.68% (Q4 2025), and 34.96% (Q3 2025), per Business Quant data.